https://www.selleckchem.com/pr....oducts/etomoxir-na-s
68 in the second year, and 3.84 in the third year, and the mean number of injections was 4.70 in the first year, 2.08 in the second year, and 1.51 in the third year. The mean BCVA change between the first visit and the first, second, and third years was not statistically significant (p0.05), and a significant change was observed in the mean central macular thickness (p0.05). Anatomical and functional success was achieved with anti-VEGF treatment after fewer injections and visits than have been reported in randomized, co
Like
Comment
Share
